Supermax Corporation Bhd’s associate company, Supermax Brasil Importadora S/A (Supermax Brasil), plans to establish a medical glove manufacturing facility in Paraná, Brazil, with a total investment commitment of about 250 million Brazilian Real (US$50 million).
Supermax said the investment marks a major step in the group’s international expansion strategy and strengthens its presence in the Latin American healthcare and industrial markets.
The group noted that Brazil offers strong long-term growth potential due to its expanding healthcare sector, rising regional demand for medical and industrial gloves, strategic access to the Mercosur market, and government initiatives aimed at boosting local manufacturing while reducing reliance on imports.
The project will involve the development of an integrated manufacturing facility with flexible production capabilities designed to serve both healthcare and industrial markets across the region. Supermax Brasil is currently working closely with Brazilian authorities and stakeholders to support the project’s implementation and the development of a local manufacturing ecosystem.
The company also plans to expand its market reach into Mercosur associate member countries, including Chile, Colombia, Ecuador, Guyana, Panama, Peru and Suriname.
Supermax said the investment will be carried out in two phases. The first phase involves an initial investment of about 150 million Brazilian Real (US$30 million), which will be funded through internally generated funds and retained earnings. The second phase will focus on future expansion to support rising regional demand and market growth.
Separately, Supermax reported a wider net loss of RM41.14 million for the third quarter ended March 31, 2026, compared with RM23.81 million a year earlier. Revenue declined to RM126.76 million from RM203.67 million, mainly due to the stronger ringgit against the US dollar and lower average selling prices.
For the first nine months of the financial year, the group’s net loss widened to RM234.19 million from RM93.35 million previously, while revenue fell to RM519.76 million from RM627.11 million.
Despite ongoing cost pressures, Supermax said it remains optimistic about its outlook, supported by resilient healthcare demand and improving overseas market conditions. The group added that it is working towards a turnaround and expects to return to profitability in the second half of 2026.
